Literature DB >> 2891556

Isolation of hemopoietic stem cell subsets from murine bone marrow: I. Radioprotective ability of purified cell suspensions differing in the proportion of day-7 and day-12 CFU-S.

R E Ploemacher1, N H Brons.   

Abstract

We have studied the ability of bone marrow cell suspensions greatly differing in the relative proportion of day-7 and day-12 spleen colony-forming units (CFU-S) to rescue mice from radiation-inflicted death, and to repopulate the irradiated bone marrow and spleen with nucleated cells. Counterflow centrifugal elutriation in combination with removal of adherent cells and fluorescence-activated cell sorting on differences in wheat germ agglutinin (WGA)-fluorescein isothiocyanate (FITC) affinity and light scatter properties were used consecutively to enrich large numbers of hemopoietic stem cells from mouse bone marrow. Enrichments of 50- to 200-fold have been achieved for day-12 CFU-S and radioprotective ability (RPA), permitting 50% of lethally irradiated mice to survive over a period of 30 days with as few as 50-80 donor cells. The ratio of day-7 and day-12 CFU-S in the various suspensions could be significantly modulated on the basis of their WGA binding and perpendicular light scatter characteristics. This finding enabled us to investigate the properties of day-7 and day-12 CFU-S with respect to their RPA. We found a highly significant log/log relationship between enrichment factors for (1) RPA, (2) the number of day-12 CFU-S, and (3) spleen cellularity as measured on day 13. In addition, similar numbers of sorted and unfractionated day-12 CFU-S were required to obtain the same level of protection. Enrichment for RPA was significantly less related to either the number of day-7 CFU-S injected, or the bone marrow cellularity of the irradiated mice on day 13.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2891556

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  6 in total

1.  Previously undetected human hematopoietic cell populations with short-term repopulating activity selectively engraft NOD/SCID-beta2 microglobulin-null mice.

Authors:  H Glimm; W Eisterer; K Lee; J Cashman; T L Holyoake; F Nicolini; L D Shultz; C von Kalle; C J Eaves
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  Purification and characterization of retrovirally transduced hematopoietic stem cells.

Authors:  L M Spain; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

3.  Clonal analysis of hematopoietic stem-cell differentiation in vivo.

Authors:  L G Smith; I L Weissman; S Heimfeld
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

4.  Hematopoietic stem cells in research and clinical applications: The "CD34 issue".

Authors:  Zoran Ivanovic
Journal:  World J Stem Cells       Date:  2010-04-26       Impact factor: 5.326

5.  Stem cells from birth to death: The history and the future.

Authors:  Gerald de Haan; Gary Van Zant
Journal:  J Am Aging Assoc       Date:  2002-04

6.  Transplantation of wheat germ agglutinin-positive hematopoietic cells to prevent or induce systemic autoimmune disease.

Authors:  E E Sardiña; K Sugiura; S Ikehara; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.